These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3500642)

  • 1. Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone.
    Lussier A; LeBel E
    Am J Med; 1987 Oct; 83(4B):15-8. PubMed ID: 3500642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative gastrointestinal blood loss associated with placebo, aspirin, and nabumetone as assessed by radiochromium (51Cr).
    Lussier A; Davis A; Lussier Y; Lebel E
    J Clin Pharmacol; 1989 Mar; 29(3):225-9. PubMed ID: 2786009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper gastrointestinal safety with nabumetone.
    Roth SH
    J Rheumatol Suppl; 1992 Nov; 36():74-9. PubMed ID: 1474539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nabumetone and aspirin on colonic mucosal bleeding time.
    Basson MD; Panzini L; Palmer RH
    Aliment Pharmacol Ther; 2001 Apr; 15(4):539-42. PubMed ID: 11284783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal blood loss of oxaprozin and aspirin with placebo control.
    Lussier A; LeBel E; Tétreault L
    J Clin Pharmacol; 1982 Apr; 22(4):173-8. PubMed ID: 6980231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nabumetone in the treatment of skin and soft tissue injury.
    Jenner PN
    Am J Med; 1987 Oct; 83(4B):101-6. PubMed ID: 3318420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of elderly patients with nabumetone or diclofenac: gastrointestinal safety profile.
    Morgan GJ; Kaine J; DeLapp R; Palmer R
    J Clin Gastroenterol; 2001 Apr; 32(4):310-4. PubMed ID: 11276273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin.
    Bernhard GC; Appelrouth DJ; Bankhurst AD; Biundo J; Bockow BI; Brobyn RD; Brodsky AL; Burch FX; Chang RW; Cohen MH
    Am J Med; 1987 Oct; 83(4B):44-9. PubMed ID: 3318428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis in adults.
    Appelrouth DJ; Baim S; Chang RW; Cohen MH; Englund DW; Germain BF; Hartman SS; Jaffer A; Mullen BJ; Smith FE
    Am J Med; 1987 Oct; 83(4B):78-81. PubMed ID: 3318434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of gastrointestinal microbleeding caused by aspirin, fenbufen, and placebo.
    Lussier A; Tétreault L; Lebel E
    Am J Med; 1983 Oct; 75(4B):80-3. PubMed ID: 6605682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a six-month study comparing the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis.
    Mullen BJ
    Am J Med; 1987 Oct; 83(4B):74-7. PubMed ID: 3318433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal blood loss after non-steroidal anti-inflammatory drugs. Measurement by selective determination of faecal porphyrins.
    Cohen A; Boeijinga JK; van Haard PM; Schoemaker RC; van Vliet-Verbeek A
    Br J Clin Pharmacol; 1992 Jan; 33(1):33-8. PubMed ID: 1540488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal blood loss induced by bromfenac sodium, aspirin, and placebo.
    Cohen A
    Clin Ther; 1995; 17(6):1110-7. PubMed ID: 8750402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nabumetone therapy of osteoarthritis. A six-week, placebo-controlled study.
    Blechman WJ
    Am J Med; 1987 Oct; 83(4B):70-3. PubMed ID: 3318432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal blood loss after a new anti-inflammatory drug, sulindac.
    Cohen A
    Clin Pharmacol Ther; 1976 Aug; 20(2):238-40. PubMed ID: 1084825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal microbleeding in normal subjects receiving acetylsalicylic acid, placebo, and R-803, a new antiinflammatory agent, in a design balanced for residual effects.
    Arsenault A; LeBel E; Lussier A
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):473-80. PubMed ID: 1086311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec, diclofenac, and naproxen in a population based cohort study.
    Ashworth NL; Peloso PM; Muhajarine N; Stang M
    J Rheumatol; 2005 Nov; 32(11):2212-7. PubMed ID: 16265705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nabumetone on hemostasis during arthroscopic knee surgery.
    Schnitzer TJ; Donahue JR; Toomey EP; Holtby RM; Scuderi GR; Adams PL; Poland MP
    Clin Ther; 1998; 20(1):110-24. PubMed ID: 9522109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of a 51Cr technique to detect gastrointestinal microbleeding associated with nonsteroidal antiinflammatory drugs.
    Lussier A; Arsenault A; Varady J; de Médicis R; Lussier Y; LeBel E
    Semin Arthritis Rheum; 1988 Feb; 17(3 Suppl 2):40-5. PubMed ID: 3334109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.